Bolt Biotherapeutics, Inc. (BOLT) stock
BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 11/3034% below fair value
$5.91−0.35 (-5.59%)
Close on Nov 12, 2026Market cap $11.38MP/E –Yield –
Bolt Biotherapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Bolt Biotherapeutics's profit margin for the twelve months ending Jun 30, 2026 was -611.5%. For fiscal 2025 it was -433.7%, against -820.8% the year before. The highest annual figure on record is -433.7% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -433.7% | +387.0 |
| FY2024 | Dec 31, 2024 | -820.8% | +57.8 |
| FY2023 | Dec 31, 2023 | -878.6% | +659.2 |
| FY2022 | Dec 31, 2022 | -1537.8% | +6286.9 |
| FY2021 | Dec 31, 2021 | -7824.7% | +18464.5 |
| FY2020 | Dec 31, 2020 | -26289.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -154400.0% | −153925.4 |
| Q1 FY2026 | Mar 31, 2026 | -27861.5% | −26958.1 |
| Q4 FY2025 | Dec 31, 2025 | -265.2% | +1064.8 |
| Q3 FY2025 | Sep 30, 2025 | -329.4% | +1333.0 |
| Q2 FY2025 | Jun 30, 2025 | -474.6% | −269.6 |
| Q1 FY2025 | Mar 31, 2025 | -903.4% | −46.4 |
| Q3 FY2024 | Sep 30, 2024 | -1330.1% | −687.0 |
| Q2 FY2024 | Jun 30, 2024 | -1662.4% | −402.3 |
| Q1 FY2024 | Mar 31, 2024 | -205.0% | +724.9 |
| Q4 FY2023 | Dec 31, 2023 | -857.0% | +560.2 |
| Q3 FY2023 | Sep 30, 2023 | -643.1% | +387.2 |
| Q2 FY2023 | Jun 30, 2023 | -1260.1% | +366.9 |
| Q1 FY2023 | Mar 31, 2023 | -929.9% | +1982.5 |
| Q4 FY2022 | Dec 31, 2022 | -1417.2% | +3928.6 |
| Q3 FY2022 | Sep 30, 2022 | -1030.3% | +2080.8 |
| Q2 FY2022 | Jun 30, 2022 | -1627.0% | +14879.0 |
| Q1 FY2022 | Mar 31, 2022 | -2912.4% | +2351.6 |
| Q4 FY2021 | Dec 31, 2021 | -5345.9% | – |
| Q3 FY2021 | Sep 30, 2021 | -3111.0% | – |
| Q2 FY2020 | Jun 30, 2020 | -16506.0% | – |
| Q1 FY2020 | Mar 31, 2020 | -5264.0% | – |
See a number that looks wrong?